| Literature DB >> 29898145 |
Weitie Wang1,2, Yuefeng Wang3, Rihao Xu2, Junwu Chai1, Wei Zhou1, Honglei Chen1, Kai Wang1, Xiangrong Kong1.
Abstract
INTRODUCTION: Preoperative renal insufficiency is an independent predictor of mortality after coronary artery bypass graft (CABG) surgery. However, there are few reports aimed to evaluate the impact of mild preoperative renal insufficiency on long-term follow-up outcomes after isolated CABG surgery. This study investigates the effect of mild preoperative renal insufficiency on long-term follow-up outcomes of patients after CABG.Entities:
Mesh:
Year: 2018 PMID: 29898145 PMCID: PMC5985842 DOI: 10.21470/1678-9741-2017-0148
Source DB: PubMed Journal: Braz J Cardiovasc Surg ISSN: 0102-7638
Baseline and procedural characteristics after matching.
| Normal group (n=304) | Mild group (n=280) | ||
|---|---|---|---|
| Age (years old) | 74.11±9.16 | 73.97±9.55 | 0.8566 |
| Older age (age >70 years) | 169 (55.59%) | 162 (57.86%) | 0.5810 |
| Older age (age >75 years) | 29 (9.53%) | 32 (11.43%) | 0.4599 |
| Male | 181 (59.54%) | 182 (65.00%) | 0.1741 |
| Obesity (BMI >30 kg/m2) | 145 (47.70%) | 146 (52.14%) | 0.2831 |
| Smoking | 171 (56.25%) | 175 (62.50%) | 0.1246 |
| NYHA class III-IV | 110 (36.18%) | 112 (40.00%) | 0.3426 |
| Previous myocardial infarction | 99 (32.57%) | 97 (34.64%) | 0.5954 |
| Previous PCI | 78 (25.66%) | 76 (27.14%) | 0.6841 |
| Hypertension | 155 (50.99%) | 148 (52.86%) | 0.6513 |
| Diabetes mellitus | 44 (14.47%) | 44 (15.71%) | 0.6755 |
| Hyperlipemia | 187 (61.51%) | 180 (64.29%) | 0.4885 |
| COPD | 28 (9.21%) | 27 (9.64%) | 0.8582 |
| Prior cerebrovascular accident | 21 (6.91%) | 19 (6.79%) | 0.9534 |
| Abnormal motion of the segmental cardiac wall | 178 (58.55%) | 174 (62.14%) | 0.3757 |
| Extent of CAD | |||
| Left main stem disease | 55 (18.09%) | 53 (18.93%) | 0.7948 |
| 3-vessel | 146 (48.02%) | 137 (48.93%) | 0.8275 |
| 2-vessel | 103 (33.88%) | 90 (32.14%) | 0.6554 |
| Baseline eGFR (ml/min/1.73 m2) | 102.39±10.58 | 75.14±6.76 | <0.0001 |
| Logistic EuroSCORE | 7.7±2.8 | 7.8±2.3 | 0.6390 |
P<0.05
BMI=body mass index; NYHA=New York Heart Association; PCI=percutaneous coronary intervention; COPD=chronic obstructive pulmonary disease; CAD=coronary artery disease; GFR=glomerular filtration rate
Intraoperative data.
| Normal group (n=304) | Mild group (n=280) | ||
|---|---|---|---|
| Operation time (min) | 331±52 | 333±51 | 0.6517 |
| No. distal anastomosis | 2.44±0.84 | 2.50±0.80 | 0.3780 |
| Perfusion time (min) | 81.9±42.4 | 81.8±43.1 | 0.9775 |
| Cross-clamp time (min) | 54.9±24.6 | 54.8±24.8 | 0.9610 |
| SVG use | 286 (94.08%) | 267 (95.36%) | 0.4913 |
| LIMA use | 198 (65.13%) | 192 (68.57%) | 0.7807 |
| RITA use | 3 (0.99%) | 2 (0.72%) | 0.7210 |
| Composite grafting | 201 (66.12%) | 194 (69.29%) | 0.4138 |
SVG=Saphenous vein graft; LIMA=left internal mammary artery; RITA=right internal thoracic artery
Postoperative outcomes.
| Normal group (n=304) | Mild group (n=280) | ||
|---|---|---|---|
| In-hospital | |||
| Surgical mortality | 3 (0.99%) | 3 (1.07%) | 0.9193 |
| Resternotomy for bleeding | 1 (0.33%) | 1 (0.36%) | 0.9535 |
| ICU stay (day) | 2.99±1.97 | 3.32±2.14 | 0.0528 |
| Hospital stay (day) | 9.52±1.50 | 9.81±2.41 | 0.0789 |
| Ventricular arrhythmia | 1 (0.33%) | 1 (0.36%) | 0.9535 |
| Low output syndrome | | 1 (0.36%) | 0.2970 |
| Stroke | 2 (0.67%) | 1 (0.36%) | 0.6115 |
| Myocardial infarction | 1 (0.33%) | 1 (0.36%) | 0.9535 |
| Atrial fibrillation | 216 (71.05%) | 208 (74.29%) | 0.3815 |
| IABP support | 7 (2.30%) | 10 (3.57%) | 0.3622 |
| AKI requiring dialysis | 2 (0.66%) | 3 (1.07%) | 0.5879 |
| Respiratory failure | __ | 1 (0.36%) | 0.2970 |
| Pneumonia | 10 (3.29%) | 9 (3.21%) | 0.9592 |
| DSWI | 6 (1.97%) | 5 (1.79%) | 0.8674 |
| CRF requiring dialysis | __ | 1 (0.36%) | 0.2970 |
| Long-term | |||
| Mortality | 15 (4.93%) | 28 (10.00%) | 0.0192 |
| Graft patency | 259 (85.20%) | 199 (71.07%) | <0.0001 |
| Additional PCI after CABG | 15 (4.93%) | 26 (9.29%) | 0.0398 |
P<0.05
ICU=intensive care unit; IABP=intra-aortic balloon pump; AKI=acute kidney injury; DSWI=deep sternal wound infection; CRF=chronic renal failure; PCI=percutaneous coronary intervention; CABG=coronary artery bypass graft
Causes of death.
| Normal group | Mild group | |
|---|---|---|
| In-hospital | ||
| No. Patients | 3 | 3 |
| Low cardiac output | 3 | 2 |
| Malignant arrhythmia | __ | 1 |
| Long-term | ||
| No. Patients | 15 | 28 |
| MACE | ||
| Heart failure | 1 | 4 |
| Myocardial infarction | 2 | 12 |
| Ventricular fibrillation | 1 | 4 |
| Sudden death | 1 | 3 |
| Cancer | 6 | 2 |
| Stroke | 4 | 1 |
| Renal failure need hemodialysis | __ | 2 |
MACE=major adverse cardiac events
Fig. 1Kaplan-Meier curves showing better long-term survival in patients with normal pre-operative renal function in comparison to mild preoperative renal insufficiency (χ2=4.255, P=0.039).
Predictors of long-term mortality.
| Variable | HR | 95% CI | |
|---|---|---|---|
| Grouping (mild group vs. normal group) | 1.78 | 1.18–2.87 | 0.026 |
| Diabetes mellitus | 1.54 | 1.15–2.64 | 0.005 |
| Prior cerebrovascular accident | 1.36 | 1.08–2.20 | 0.02 |
| Gender (female | 1.28 | 1.09–1.99 | 0.024 |
| Impaired left ventricular function | 1.21 | 1.06–1.68 | 0.019 |
| Age (per year) | 1.07 | 1.01–1.54 | <0.0001 |
| Abbreviations, acronyms & symbols | ||||
|---|---|---|---|---|
| AKI | = Acute kidney injury | EuroSCORE | = European System for Cardiac Operative Risk Evaluation | |
| CABG | = Coronary artery bypass graft surgery | GFR | = Glomerular filtration rate | |
| CAD | = Coronary artery disease | HRs | = Hazard ratios | |
| CIs | = Confidence intervals | MACE | = Major Adverse Cardiac Event | |
| CKD | = Chronic kidney disease | MI | = Myocardial infarction | |
| COPD | = Chronic obstructive pulmonary disease | NYHA | = New York Heart Association | |
| CPB | = Cardiopulmonary bypass | OPCAB | = Off-pump coronary artery bypass | |
| CRF | = Chronic renal failure | PCI | = Percutaneous coronary intervention | |
| CT | = Computed tomography | RI | = Renal insufficiency | |
| DM | = Diabetes mellitus | SD | = Standard deviation | |
| ECG | = Electrocardiogram | SVG | = Saphenous vein graft | |
| eGFR | = Estimated glomerular filtration rate | |||
| Authors' roles & responsibilities | |
|---|---|
| WW | Conceived the study, and participated in its design and coordination and helped to draft the manuscript; final approval of the version to be published |
| YW | Conceived the study, and participated in its design and coordination and helped to draft the manuscript; final approval of the version to be published |
| RX | Conceived the study, and participated in its design and coordination and helped to draft the manuscript; final approval of the version to be published |
| JC | Carried out the data collection and statistical analysis; final approval of the version to be published |
| WZ | Carried out the data collection and statistical analysis; final approval of the version to be published |
| HC | Carried out the data collection and statistical analysis; final approval of the version to be published |
| KW | Participated in the design of the study and drafted the manuscript; final approval of the version to be published |
| XK | Participated in the design of the study and drafted the manuscript; final approval of the version to be published; final approval of the version to be published |